Drug Profile
Influenza virus vaccine - Japan Vaccine/Terumo
Alternative Names: VN 100 - Japan Vaccine/TerumoLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company; Japan Vaccine; Kitasato Daiichi Sankyo Vaccine; Terumo
- Developer Daiichi Sankyo Biotech; Daiichi Sankyo Company; Japan Vaccine; Terumo
- Class Influenza virus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 31 Oct 2018 Discontinued - Phase-III for Influenza virus infections (In adolescents, Prevention, In adults) in Japan (Intradermal)
- 31 Oct 2018 Discontinued - Phase-III for Influenza virus infections (In children, Prevention) in Japan (Intradermal)
- 31 Oct 2018 Discontinued - Preregistration for Influenza virus infections (Prevention) in Japan (Intradermal)